Published on 20 Nov 2022 on American City Business Journals
Peninsula drug company Tricida cutting more than half of staff after clinical trial failure
Its stock fell more than 94% in a single day. The third kidney-focused company started...President...
Peninsula drug company Tricida cutting more than half of staff after clinical trial failure
Its stock fell more than 94% in a single day. The third kidney-focused company started...Presiden...
Tricida Shares Nosedive After Disappointing Data From Much Anticipated Kidney Disease Trial
Tricida Inc (NASDAQ: TCDA) announced the topline results from its VALOR-CKD renal outcomes clinic...
Read Why Did Tricida Stop VALOR-CKD Renal Outcomes Trial Early
Tricida Inc (NASDAQ: TCDA) said that, as anticipated, it is stopping its VALOR-CKD renal outcomes...
Is Tricida, Inc. (NASDAQ:TCDA) Popular Amongst Institutions?
If you want to know who really controls Tricida, Inc. (NASDAQ:TCDA), then you'll have to look at ...
Estimating The Fair Value Of Tricida, Inc. (NASDAQ:TCDA)
How far off is Tricida, Inc. (NASDAQ:TCDA) from its intrinsic value? Using the most recent financ...
Do Options Traders Know Something About Tricida (TCDA) Stock We Don't?
Investors in Tricida, Inc. TCDA need to pay close attention to the stock based on moves in the op...
Hedge Funds Are Crazy About Tricida, Inc. (TCDA)
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, th...
Steven Cohen Expands Health Care Holdings With Tricida
- By Sydnee Gatewood After previously exiting a position in the fourth quarter of 2020, Point72 A...
Do Hedge Funds Love Tricida, Inc. (TCDA)?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee st...
Tricida (TCDA) Sees Hammer Chart Pattern: Time to Buy?
Tricida, Inc. TCDA has been struggling lately, but the selling pressure may be coming to an end s...